Characterization of the nutrient assimilation pathways in M. tuberculosis
Project Number5R01AI150916-05
Former Number1R01AI150916-01
Contact PI/Project LeaderVANDERVEN, BRIAN C
Awardee OrganizationCORNELL UNIVERSITY
Description
Abstract Text
Project Summary / Abstract
Mtb utilizes host-derived lipids to promote pathogenesis and this is a defining feature of this intracellular
pathogen. During infection Mtb imports and metabolizes host lipids to support pathogenesis by producing: i)
energy, ii) central metabolic intermediates, or iii) polyketide virulence lipids. While the metabolic pathways in Mtb
that degrade or process lipids are complex and contain redundant enzymes, the bacterial Mce lipid transporters
appear to be specific for dedicated lipid substrates.
Aim 1 of this work proposes to employ genetic and biochemical approaches to identify and characterize novel
gene/proteins required for fatty acid import in Mtb. While it is understood that Mce1 imports fatty acids, the
substrate specificity of this transporter is unknown. Therefore, we intend to define substrates and the biochemical
basis of Mce1 substrate specificity. Our preliminary studies indicate that Mtb transports fatty acid precursors of
immune signaling lipids via Mce1 and we include here studies to evaluate if scavenging of this immune lipid
precursors by Mtb impacts the immune response.
Aim 2 proposes to identify and characterize protein subunits that are shared by all the Mce transporters and
are required for lipid import in Mtb. We have determined that LucA is required for Mce1- and Mce4-mediated
transport and LucA stabilizes these transporter complexes. These studies seek to characterize the basis for this
transporter stabilization. Similarly, MceG is required for Mce1- and Mce4-mediated transport and we intend to
understand how MceG stabilizes and interacts with Mce1. We will use a genetic approach to silence LucA and
MceG in Mtb within chronically infected mice and quantify bacterial fitness to determine the therapeutic potential
of drugs that potentially block these proteins.
Public Health Relevance Statement
Project Narrative
Mycobacterium tuberculosis is the causative agent of Tuberculosis and is responsible for approximately 1.6
million deaths annually. A key component of this disease is the bacterium’s ability to persist for long periods of
time in the human host. This proposed research will characterize mechanisms involved in nutrient acquisition by
the bacterium during infection. These studies will allow us to better understand lipid import and lipid utilization
by M. tuberculosis while determining if these pathways have therapeutic potential.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
872612445
UEI
G56PUALJ3KT5
CCV3WG2JG248
D4H1NV4APKP3
ELS2M3C6V2S5
EQA8NBEN9WD5
FFAZGE9NH3M8
K6JRCJJXFET1
M8FBSLHASMT3
P4LRVQT1H4K5
PJUVN8AT5416
RT1JPM9UMGM5
ZBMGUAZYFGC4
ZMP8BDLJTUW9
Project Start Date
19-November-2020
Project End Date
31-October-2025
Budget Start Date
01-November-2024
Budget End Date
31-October-2025
Project Funding Information for 2025
Total Funding
$527,826
Direct Costs
$345,781
Indirect Costs
$182,045
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Allergy and Infectious Diseases
$527,826
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI150916-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI150916-05
Patents
No Patents information available for 5R01AI150916-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI150916-05
Clinical Studies
No Clinical Studies information available for 5R01AI150916-05
News and More
Related News Releases
No news release information available for 5R01AI150916-05
History
No Historical information available for 5R01AI150916-05
Similar Projects
No Similar Projects information available for 5R01AI150916-05